All Stories

  1. Cophenetic Spatial Topology Embedding reveals multiscale tissue architecture in spatial omics
  2. Spatially resolved T cell receptor diversity mapping uncovers variability of the cancer immune microenvironment
  3. gSV: a general structural variant detector using the third-generation sequencing data
  4. Targeted sequencing of mutations via RNA-templated gap filling of oligonucleotides for single-cell RNA-seq
  5. gSV: a general structural variant detector using the third-generation sequencing data
  6. Direct Inference of Haplotypes from Sequencing Data
  7. Comparing Xenium 5K and Visium HD data from identical tissue slide at a pathological perspective
  8. Optimizing Xenium In Situ data utility by quality assessment and best-practice analysis workflows
  9. Imaging flow cytometry with a real-time throughput beyond 1,000,000 events per second
  10. MRRM: Advanced Biomarker Alignment in Multi-Staining Pathology Images via Multi-Scale Ring Rotation-Invariant Matching
  11. BVSim: A benchmarking variation simulator mimicking human variation spectrum
  12. Parallel Analyses by Mass Spectrometry (MS) and Reverse Phase Protein Array (RPPA) Reveal Complementary Proteomic Profiles in Triple‐Negative Breast Cancer (TNBC) Patient Tissues and Cell Cultures
  13. cascAGS: Comparative Analysis of SNP Calling Methods for Human Genome Data in the Absence of Gold Standard
  14. CellSAM: Advancing Pathologic Image Cell Segmentation via Asymmetric Large‐Scale Vision Model Feature Distillation Aggregation Network
  15. Proteomics Landscape of Triple-Negative Apocrine Breast Carcinoma Reveals Molecular Mechanisms of Tumorigenesis and Characteristics of Chemo-insensitivity
  16. Bridging Discoveries and Treatments: The New Landscape of Breast Cancer Research
  17. Parallel Analyses by Mass Spectrometry (MS) and Reverse Phase Protein Array (RPPA) Reveal Complementary Proteomic Profiles in Triple-Negative Breast Cancer (TNBC) Patient Tissues and Cell Cultures
  18. MSGM: An Advanced Deep Multi-Size Guiding Matching Network for Whole Slide Histopathology Images Addressing Staining Variation and Low Visibility Challenges
  19. Loss of Human Epidermal Receptor 2 Expression in Formalin-Fixed Paraffin-Embedded Breast Cancer Samples and the Rescuing Effect of Enhanced Antigen Retrieval and Signal Amplification
  20. An orientation-free ring feature descriptor with stain-variability normalization for pathology image matching
  21. Author Correction: The landscape of viral associations in human cancers
  22. Author Correction: Butler enables rapid cloud-based analysis of thousands of human genomes
  23. Author Correction: Comprehensive analysis of chromothripsis in 2,658 human cancers using whole-genome sequencing
  24. Author Correction: Comprehensive molecular characterization of mitochondrial genomes in human cancers
  25. Author Correction: Disruption of chromatin folding domains by somatic genomic rearrangements in human cancer
  26. Author Correction: Pan-cancer analysis of whole genomes identifies driver rearrangements promoted by LINE-1 retrotransposition
  27. Author Correction: Pan-cancer analysis of whole genomes
  28. Author Correction: Analyses of non-coding somatic drivers in 2,658 cancer whole genomes
  29. Author Correction: Genomic basis for RNA alterations in cancer
  30. Author Correction: Patterns of somatic structural variation in human cancer genomes
  31. Author Correction: The evolutionary history of 2,658 cancers
  32. Author Correction: The repertoire of mutational signatures in human cancer
  33. Biomarker Alteration after Neoadjuvant Endocrine Therapy or Chemotherapy in Estrogen Receptor-Positive Breast Cancer
  34. Author Correction: A deep learning system accurately classifies primary and metastatic cancers using passenger mutation patterns
  35. Author Correction: Combined burden and functional impact tests for cancer driver discovery using DriverPower
  36. Author Correction: Divergent mutational processes distinguish hypoxic and normoxic tumours
  37. Author Correction: Genomic footprints of activated telomere maintenance mechanisms in cancer
  38. Author Correction: Inferring structural variant cancer cell fraction
  39. Author Correction: Integrative pathway enrichment analysis of multivariate omics data
  40. Author Correction: Pathway and network analysis of more than 2500 whole cancer genomes
  41. Author Correction: Reconstructing evolutionary trajectories of mutation signature activities in cancer using TrackSig
  42. Author Correction: High-coverage whole-genome analysis of 1220 cancers reveals hundreds of genes deregulated by rearrangement-mediated cis-regulatory alterations
  43. Author Correction: Cancer LncRNA Census reveals evidence for deep functional conservation of long noncoding RNAs in tumorigenesis
  44. Adverse Events of PD-1 or PD-L1 Inhibitors in Triple-Negative Breast Cancer: A Systematic Review and Meta-Analysis
  45. Survival in Breast Cancer Patients with Bone Metastasis: A Multicenter Real-World Study on the Prognostic Impact of Intensive Postoperative Bone Scan after Initial Diagnosis of Breast Cancer (CSBrS-023)
  46. Assessment of accuracy in identifying structural variants using third-generation sequencing for breast cancer in the absence of gold standard
  47. AR Expression Correlates with Distinctive Clinicopathological and Genomic Features in Breast Cancer Regardless of ESR1 Expression Status
  48. Germline Variants in 32 Cancer-Related Genes among 700 Chinese Breast Cancer Patients by Next-Generation Sequencing: A Clinic-Based, Observational Study
  49. Two-Dose Vaccination Significantly Prolongs the Duration from Symptom Onset to Death: A Retrospective Study Based on 173,894 SARS-CoV-2 Cases in Khyber Pakhtunkhwa, Pakistan
  50. Tunable mechanical and degradation properties of biodegradable Mg-Y-Zn alloys via Zn content regulation
  51. HER2-low-positive features a distinct subtype in estrogen receptor-positive breast cancer associated with endocrine therapy resistance
  52. Expression of DNA Helicase Genes Was Correlated with Homologous Recombination Deficiency in Breast Cancer
  53. BM-Net: CNN-Based MobileNet-V3 and Bilinear Structure for Breast Cancer Detection in Whole Slide Images
  54. Androgen receptor expression associates with distinctive clinicopathological and molecular features in ER-positive and ER-negative breast cancer
  55. Intraparenchymal breast leiomyoma and atypical leiomyoma
  56. Detection of Structural Variations and Fusion Genes in Breast Cancer Samples Using Third-Generation Sequencing
  57. Gene expression trend changes in breast cancer populations over two decades: insights from The Cancer Genome Atlas database
  58. Triple-Negative Apocrine Breast Carcinoma Has Better Prognosis despite Poor Response to Neoadjuvant Chemotherapy
  59. The natural history of breast cancer: a chronological analysis of breast cancer progression using data from the SEER database
  60. Triple negative apocrine breast carcinoma has better prognosis despite poor response to neoadjuvant chemotherapy
  61. Modeling effective tumor burden of primary lesion and metastatic lymph node in breast cancer patients from the SEER database
  62. Gene expression trend changes in breast cancer populations over two decades: insights from The Cancer Genome Atlas database
  63. Detection of structural variations and fusion genes in breast cancer samples using third-generation sequencing
  64. Identification and Functional Characterization of a Novel Nonsense Variant in ARR3 in a Southern Chinese Family With High Myopia
  65. Androgen Receptor Expression Associates With Distinctive Clinicopathological and Molecular Features in ER-Positive and ER-Negative Breast Cancer
  66. Gene expression trend changes in breast cancer populations over two decades: insights from The Cancer Genome Atlas database
  67. Androgen Receptor Expression Associates With Distinctive Clinicopathological and Molecular Features in ER-Positive and ER-Negative Breast Cancer
  68. Detection of structural variations and fusion genes in breast cancer samples using third-generation sequencing
  69. Intraparenchymal Breast Leiomyoma and Atypical Leiomyoma
  70. Classification of PR-positive and PR-negative subtypes in ER-positive and HER2-negative breast cancers based on pathway scores
  71. Prognosis classification of breast cancer with distant lymph node metastasis IIIc or M1 category
  72. Evaluating and Balancing the Risk of Breast Cancer-Specific Death and Other Cause-Specific Death in Elderly Breast Cancer Patients
  73. A Histone Acetylation Modulator Gene Signature for Classification and Prognosis of Breast Cancer
  74. Mechanism and effect of stress granule formation in cancer and its potential roles in breast cancer therapy
  75. Protective effect of goserelin on ovarian reserve during (neo)adjuvant chemotherapy in young breast cancer patients: a prospective cohort study in China
  76. RECQL5 KIX domain splicing isoforms have distinct functions in transcription repression and DNA damage response
  77. A Machine Learning Approach to Differentiate Two Specific Breast Cancer Subtypes Using Androgen Receptor Pathway Genes
  78. Author Correction: Retrospective evaluation of whole exome and genome mutation calls in 746 cancer samples
  79. Retrospective evaluation of whole exome and genome mutation calls in 746 cancer samples
  80. Sex differences in oncogenic mutational processes
  81. Highly Recurrent Copy Number Variations in GABRB2 Associated With Schizophrenia and Premenstrual Dysphoric Disorder
  82. Author Correction: Comprehensive molecular characterization of mitochondrial genomes in human cancers
  83. Publisher Correction: Comprehensive molecular characterization of mitochondrial genomes in human cancers
  84. Detecting viruses in tumour tissue to discover links between cancer and infection
  85. Inferring structural variant cancer cell fraction
  86. Reconstructing evolutionary trajectories of mutation signature activities in cancer using TrackSig
  87. Analyses of non-coding somatic drivers in 2,658 cancer whole genomes
  88. Cancer LncRNA Census reveals evidence for deep functional conservation of long noncoding RNAs in tumorigenesis
  89. A deep learning system accurately classifies primary and metastatic cancers using passenger mutation patterns
  90. Combined burden and functional impact tests for cancer driver discovery using DriverPower
  91. Divergent mutational processes distinguish hypoxic and normoxic tumours
  92. Genomic footprints of activated telomere maintenance mechanisms in cancer
  93. High-coverage whole-genome analysis of 1220 cancers reveals hundreds of genes deregulated by rearrangement-mediated cis-regulatory alterations
  94. Integrative pathway enrichment analysis of multivariate omics data
  95. Pathway and network analysis of more than 2500 whole cancer genomes
  96. Comprehensive analysis of chromothripsis in 2,658 human cancers using whole-genome sequencing
  97. Comprehensive molecular characterization of mitochondrial genomes in human cancers
  98. Disruption of chromatin folding domains by somatic genomic rearrangements in human cancer
  99. Pan-cancer analysis of whole genomes identifies driver rearrangements promoted by LINE-1 retrotransposition
  100. Butler enables rapid cloud-based analysis of thousands of human genomes
  101. Genomic basis for RNA alterations in cancer
  102. Patterns of somatic structural variation in human cancer genomes
  103. The repertoire of mutational signatures in human cancer
  104. Pan-cancer analysis of whole genomes
  105. The evolutionary history of 2,658 cancers
  106. Genomic subtyping of liver cancers with prognostic application
  107. Natural History of Breast Cancer: Reanalyze Nodal Stage and Oestrogen Receptor Status Affecting the Progression of Breast Cancer from SEER Database
  108. Transcriptional regulation of Bcl-2 gene by the PR/SET domain family member PRDM10
  109. Characteristics and Prognostic Factors of Patients With Osteosarcoma Older Than 60 Years From the SEER Database
  110. AluScanCNV2: An R package for copy number variation calling and cancer risk prediction with next-generation sequencing data
  111. Forward and reverse mutations in stages of cancer development
  112. Forward-reverse mutation cycles between stages of cancer development
  113. Coevolution Theory of the Genetic Code at Age Forty: Pathway to Translation and Synthetic Life
  114. Tripartite genome of all species
  115. Feature co-localization landscape of the human genome
  116. GABRB2 Haplotype Association with Heroin Dependence in Chinese Population
  117. Massive interstitial copy-neutral loss-of-heterozygosity as evidence for cancer being a disease of the DNA-damage response
  118. The genetic equidistance result: misreading by the molecular clock and neutral theory and reinterpretation nearly half of a century later